National surveillance of invasive pneumococcal diseases in Taiwan, 2008-2012: differential temporal emergence of serotype 19A. (Q39199044)

9 September 2017

National surveillance of invasive pneumococcal diseases in Taiwan, 2008-2012: differential temporal emergence of serotype 19A. (English)

1 reference

9 September 2017

Chuen-Sheue Chiang

1

1 reference

9 September 2017

Ying-Yan Chen

2

1 reference

9 September 2017

Shr-Fong Jiang

3

1 reference

9 September 2017

Ding-Ping Liu

4

1 reference

9 September 2017

Pei-Hsiu Kao

5

1 reference

9 September 2017

Hwa-Jen Teng

6

1 reference

9 September 2017

Tsung-Lin Kuo

7

1 reference

9 September 2017

Shu-Man Yao

8

1 reference

9 September 2017

Lei-Ron Tseng

9

1 reference

9 September 2017

Yu-Lan Wang

10

1 reference

9 September 2017

Ho-Sheng Wu

11

1 reference

9 September 2017

Feng-Yee Chang

12

1 reference

9 September 2017

Tzou-Yien Lin

13

1 reference

9 September 2017

language of work or name

English

0 references

publication date

29 April 2014

1 reference

9 September 2017

1 reference

9 September 2017

32

1 reference

9 September 2017

27

1 reference

9 September 2017

3345-3349

1 reference

Invasive pneumococcal disease

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Effectiveness of pneumococcal polysaccharide vaccine in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Pneumococcal disease surveillance in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

The impact of the heptavalent pneumococcal conjugate vaccine on risk factors for Streptococcus pneumoniae carriage in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Risk factors for primary invasive pneumococcal disease among children in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

inferred from DOI database lookup

7 January 2021

based on heuristic

Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

New variants and age shift to high fatality groups contribute to severe successive waves in the 2009 influenza pandemic in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.061

10.1016/J.VACCINE.2014.04.061

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference